{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T13:17:16Z","timestamp":1775308636428,"version":"3.50.1"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1097\/fpc.0b013e3282f49964","type":"journal-article","created":{"date-parts":[[2009,3,4]],"date-time":"2009-03-04T18:56:51Z","timestamp":1236193011000},"page":"141-151","source":"Crossref","is-referenced-by-count":21,"title":["A novel promoter polymorphism in the human gene GNAS affects binding of transcription factor upstream stimulatory factor 1, G\u03b1s protein expression and body weight regulation"],"prefix":"10.1097","volume":"18","author":[{"given":"Ulrich H.","family":"Frey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans","family":"Hauner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl-Heinz","family":"J\u00f6ckel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iris","family":"Manthey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norbert","family":"Brockmeyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Winfried","family":"Siffert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-7-20210212","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1001\/jama.289.2.187","article-title":"Years of life lost due to obesity","volume":"289","author":"Fontaine","year":"2003","journal-title":"JAMA"},{"key":"R2-7-20210212","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1161\/01.CIR.67.5.968","article-title":"Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study","volume":"67","author":"Hubert","year":"1983","journal-title":"Circulation"},{"issue":"2","key":"R3-7-20210212","first-page":"51S","article-title":"Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: the evidence report","volume":"6","year":"1998","journal-title":"Obes Res"},{"key":"R4-7-20210212","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0140-6736(07)60033-6","article-title":"Drug treatments for obesity: orlistat, sibutramine, and rimonabant","volume":"369","author":"Padwal","year":"2007","journal-title":"Lancet"},{"key":"R5-7-20210212","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/j.1550-8528.1999.tb00701.x","article-title":"Sibutramine produces dose-related weight loss","volume":"7","author":"Bray","year":"1999","journal-title":"Obes Res"},{"key":"R6-7-20210212","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0002-9343(98)00411-2","article-title":"Long-term maintenance of weight loss after a very-low-calorie diet: a randomized blinded trial of the efficacy and tolerability of sibutramine","volume":"106","author":"Apfelbaum","year":"1999","journal-title":"Am J Med"},{"key":"R7-7-20210212","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1016\/S0140-6736(00)03491-7","article-title":"Effect of sibutramine on weight maintenance after weight loss: a randomised trial. STORM Study Group. Sibutramine Trial of Obesity Reduction and Maintenance","volume":"356","author":"James","year":"2000","journal-title":"Lancet"},{"key":"R8-7-20210212","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1001\/jama.286.11.1331","article-title":"Long-term weight loss with sibutramine: a randomized controlled trial","volume":"286","author":"Wirth","year":"2001","journal-title":"JAMA"},{"key":"R9-7-20210212","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1159\/000047310","article-title":"Randomized, double-blind, placebo-controlled, multicenter study of sibutramine in obese hypertensive patients","volume":"94","author":"Hazenberg","year":"2000","journal-title":"Cardiology"},{"key":"R10-7-20210212","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/sj.jhh.1001298","article-title":"Sibutramine is safe and effective for weight loss in obese patients whose hypertension is well controlled with angiotensin-converting enzyme inhibitors","volume":"16","author":"McMahon","year":"2002","journal-title":"J Hum Hypertens"},{"key":"R11-7-20210212","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1046\/j.1467-789x.2000.00020.x","article-title":"An assessment of the safety and efficacy of sibutramine, an anti-obesity drug with a novel mechanism of action","volume":"1","author":"Nisoli","year":"2000","journal-title":"Obes Rev"},{"key":"R12-7-20210212","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1210\/jc.2006-2499","article-title":"Sympathetic vasomotor tone determines blood pressure response to long-term sibutramine treatment","volume":"92(4)","author":"Heusser","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"R13-7-20210212","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.clpt.2006.02.002","article-title":"Influence of sibutramine treatment on sympathetic vasomotor tone in obese subjects","volume":"79","author":"Heusser","year":"2006","journal-title":"Clin Pharmacol Ther"},{"key":"R14-7-20210212","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1161\/01.CIR.0000036370.31856.73","article-title":"Paradoxical effect of sibutramine on autonomic cardiovascular regulation","volume":"106","author":"Birkenfeld","year":"2002","journal-title":"Circulation"},{"key":"R15-7-20210212","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.2165\/00002018-200326140-00004","article-title":"A benefit-risk assessment of sibutramine in the management of obesity","volume":"26","author":"Nisoli","year":"2003","journal-title":"Drug Saf"},{"key":"R16-7-20210212","doi-asserted-by":"crossref","first-page":"5459","DOI":"10.1210\/en.2004-0865","article-title":"GNAS: normal and abnormal functions","volume":"145","author":"Weinstein","year":"2004","journal-title":"Endocrinology"},{"key":"R17-7-20210212","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/382622a0","article-title":"Genetically lean mice result from targeted disruption of the RII beta subunit of protein kinase A","volume":"382","author":"Cummings","year":"1996","journal-title":"Nature"},{"key":"R18-7-20210212","first-page":"27","article-title":"Transgenic mice overexpressing the beta 1-adrenergic receptor in adipose tissue are resistant to obesity","volume":"11","author":"Soloveva","year":"1997","journal-title":"Mol Endocrinol"},{"key":"R19-7-20210212","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1172\/JCI8437","article-title":"Paternal versus maternal transmission of a stimulatory G-protein alpha subunit knockout produces opposite effects on energy metabolism","volume":"105","author":"Yu","year":"2000","journal-title":"J Clin Invest"},{"key":"R20-7-20210212","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/ng1397","article-title":"The imprinted signaling protein XL alpha s is required for postnatal adaptation to feeding","volume":"36","author":"Plagge","year":"2004","journal-title":"Nat Genet"},{"key":"R21-7-20210212","doi-asserted-by":"crossref","first-page":"7386","DOI":"10.1073\/pnas.0408268102","article-title":"Alternative Gnas gene products have opposite effects on glucose and lipid metabolism","volume":"102","author":"Chen","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R22-7-20210212","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/nrg2063","article-title":"The evolutionary significance of cis-regulatory mutations","volume":"8","author":"Wray","year":"2007","journal-title":"Nat Rev Genet"},{"key":"R23-7-20210212","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1097\/00008571-200312000-00006","article-title":"Successful amplification of extremely GC-rich promoter regions using a novel \u2018slowdown PCR\u2019 technique","volume":"13","author":"Bachmann","year":"2003","journal-title":"Pharmacogenetics"},{"key":"R24-7-20210212","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1172\/JCI118120","article-title":"Enhanced G protein activation in immortalized lymphoblasts from patients with essential hypertension","volume":"96","author":"Siffert","year":"1995","journal-title":"J Clin Invest"},{"key":"R25-7-20210212","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1530\/eje.0.1410436","article-title":"Depot-specific release of leptin from subcutaneous and omental adipocytes in suspension culture: effect of tumor necrosis factor-alpha and transforming growth factor-beta1","volume":"141","author":"Gottschling-Zeller","year":"1999","journal-title":"Eur J Endocrinol"},{"key":"R26-7-20210212","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/0003-2697(89)90027-4","article-title":"Automatic luminometric kinetic assay of glycerol for lipolysis studies","volume":"177","author":"Hellmer","year":"1989","journal-title":"Anal Biochem"},{"key":"R27-7-20210212","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1055\/s-2004-817934","article-title":"Weight reduction by sibutramine in obese subjects in primary care medicine: the SAT Study","volume":"112","author":"Hauner","year":"2004","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"R28-7-20210212","doi-asserted-by":"crossref","first-page":"30558","DOI":"10.1074\/jbc.272.48.30558","article-title":"Molecular variation of the human angiotensinogen core promoter element located between the TATA box and transcription initiation site affects its transcriptional activity","volume":"272","author":"Yanai","year":"1997","journal-title":"J Biol Chem"},{"key":"R29-7-20210212","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0092-8674(88)90469-2","article-title":"Mapping protein-DNA interactions in vivo with formaldehyde: evidence that histone H4 is retained on a highly transcribed gene","volume":"53","author":"Solomon","year":"1988","journal-title":"Cell"},{"key":"R30-7-20210212","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.2337\/diabetes.54.7.1976","article-title":"Role of upstream stimulatory factors in regulation of renal transforming growth factor-beta1","volume":"54","author":"Zhu","year":"2005","journal-title":"Diabetes"},{"key":"R31-7-20210212","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2337\/diabetes.51.2.293","article-title":"Transcriptional regulation of adipocyte hormone-sensitive lipase by glucose","volume":"51","author":"Smith","year":"2002","journal-title":"Diabetes"},{"key":"R32-7-20210212","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/ng1320","article-title":"Familial combined hyperlipidemia is associated with upstream transcription factor 1 (USF1)","volume":"36","author":"Pajukanta","year":"2004","journal-title":"Nat Genet"},{"key":"R33-7-20210212","doi-asserted-by":"crossref","first-page":"393","DOI":"10.2165\/00007256-200535050-00003","article-title":"Interactions of metabolic hormones, adipose tissue and exercise","volume":"35","author":"McMurray","year":"2005","journal-title":"Sports Med"},{"key":"R34-7-20210212","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1055\/s-2006-955083","article-title":"The primary amine metabolite of sibutramine stimulates lipolysis in adipocytes isolated from lean and obese mice and in isolated human adipocytes","volume":"38","author":"Richardson","year":"2006","journal-title":"Horm Metab Res"},{"key":"R35-7-20210212","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/j.1748-1716.1984.tb07546.x","article-title":"Relationship between the overflow of endogenous and radiolabelled noradrenaline from canine blood perfused gracilis muscle","volume":"122","author":"Kahan","year":"1984","journal-title":"Acta Physiol Scand"},{"key":"R36-7-20210212","first-page":"R824","article-title":"Central sympathoinhibition and peripheral neuronal uptake blockade after desipramine in rabbits","volume":"260","author":"Eisenhofer","year":"1991","journal-title":"Am J Physiol"},{"key":"R37-7-20210212","doi-asserted-by":"crossref","first-page":"5130","DOI":"10.1210\/jc.2002-020533","article-title":"Norepinephrine transporter function and autonomic control of metabolism","volume":"87","author":"Boschmann","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"R38-7-20210212","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1161\/01.RES.78.4.517","article-title":"Adverse effects of chronic endogenous sympathetic drive induced by cardiac GS alpha overexpression","volume":"78","author":"Iwase","year":"1996","journal-title":"Circ Res"}],"container-title":["Pharmacogenetics and Genomics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/01213011-200802000-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,14]],"date-time":"2021-04-14T01:48:54Z","timestamp":1618364934000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01213011-200802000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/fpc.0b013e3282f49964","relation":{},"ISSN":["1744-6872"],"issn-type":[{"value":"1744-6872","type":"print"}],"subject":[],"published":{"date-parts":[[2008,2]]}}}